The FDA has granted #BreakthroughTherapy designation to Stoke Therapeutics' #Zorevunersen for Dravet syndrome!

✅ Reduces seizures
✅ Improves cognition &amp; behavior
✅ Long-term safety

Learn more:#fdaapproval #epilepsytreatment #neurologicaldisorders
#BreakthroughTherapy #Zorevunersen #fdaapproval #epilepsytreatment #neurologicaldisorders